1.	Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal Cancer Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000350080, MSKCC-03113, ROCHE-NO17320, NCT00077259
2.	Phase II Study of Epothilone D in Patients With Stage IIIB or IV Non-Small Cell Lung Cancer Who Failed Prior Initial Platinum-Containing Chemotherapy Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: MSKCC-03134, ROCHE-N017352, KOS-201, NCT00081107
3.	A Study of Epothilone D in Combination With Herceptin (Trastuzumab) in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer. Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: NO17328, NCT00337649